Nordine 2 Injection contains Norepinephrine 2 mg, a potent vasopressor used in acute hypotensive emergencies, septic shock, and critical care settings to maintain adequate blood pressure and perfusion.
This injection works by stimulating alpha-adrenergic receptors, leading to constriction of blood vessels, improved vascular resistance, and stabilization of systemic blood pressure in critically ill patients.
Belonging to the cardiology and critical care segment, Nordine 2 is indispensable in ICU, emergency, and post-surgical care, making it a high-demand product in hospitals and specialty care units across India.
For PCD pharma franchise partners, wholesalers, exporters, and third-party manufacturers, Nordine 2 Injection provides a profitable B2B opportunity in the critical care segment, ensuring steady demand and institutional adoption.
Possible side effects include headache, anxiety, palpitations, rapid heart rate, and hypertension. Rarely, it may cause tissue necrosis at the injection site, arrhythmias, or severe allergic reactions. Seek immediate medical attention if severe complications occur.
Nordine 2 Injection is indicated for the management of acute hypotension, septic shock, or severe low blood pressure that does not respond adequately to fluid replacement. It helps restore and maintain adequate blood pressure and organ perfusion in critical care settings.
Nordine 2 Injection must be administered only under strict medical supervision, typically via an intravenous infusion. Continuous monitoring of blood pressure, heart rate, and tissue perfusion is essential. Inform your doctor of any heart conditions, arrhythmias, or use of other vasopressors.
Store Nordine 2 Injection in a cool, dry place below 25°C, protected from light. Keep the vial tightly closed and out of reach of children.